Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry


Kabasakal L., Toklu T., Yeyin N., Demirci E. , Abuqbeitah M., Ocak M. , ...Daha Fazla

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.26, ss.62-68, 2017 (ESCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 26 Konu: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/mirt.08760
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Sayfa Sayıları: ss.62-68

Özet

Objective: The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617.